These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 32044149)

  • 1. Natural Killer cell transcriptome during primary EBV infection and EBV associated Hodgkin Lymphoma in children-A preliminary observation.
    M A; Chatterjee S; A P; S M; Davuluri S; Ar AK; T A; M P; Cs P; Sinha M; Chugani A; R VP; Kk A; R S J
    Immunobiology; 2020 May; 225(3):151907. PubMed ID: 32044149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
    Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
    Front Immunol; 2020; 11():1231. PubMed ID: 32625211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.
    Abbott RJ; Pachnio A; Pedroza-Pacheco I; Leese AM; Begum J; Long HM; Croom-Carter D; Stacey A; Moss PAH; Hislop AD; Borrow P; Rickinson AB; Bell AI
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential chemokine, chemokine receptor and cytokine expression in Epstein-Barr virus-associated lymphoproliferative diseases.
    Ohshima K; Karube K; Hamasaki M; Tutiya T; Yamaguchi T; Suefuji H; Suzuki K; Suzumiya J; Ohga S; Kikuchi M
    Leuk Lymphoma; 2003 Aug; 44(8):1367-78. PubMed ID: 12952231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells.
    Djaoud Z; Guethlein LA; Horowitz A; Azzi T; Nemat-Gorgani N; Olive D; Nadal D; Norman PJ; Münz C; Parham P
    J Exp Med; 2017 Jun; 214(6):1827-1841. PubMed ID: 28468758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
    Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
    mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations in
    Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
    Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced frequency of cytotoxic CD56
    Pánisová E; Lünemann A; Bürgler S; Kotur M; Lazarovici J; Danu A; Kaulfuss M; Mietz J; Chijioke O; Münz C; Busson P; Berger C; Ghez D; Azzi T
    Cancer Immunol Immunother; 2022 Jan; 71(1):13-24. PubMed ID: 33993319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells.
    Flavell JR; Baumforth KR; Wood VH; Davies GL; Wei W; Reynolds GM; Morgan S; Boyce A; Kelly GL; Young LS; Murray PG
    Blood; 2008 Jan; 111(1):292-301. PubMed ID: 17720884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune responses against Epstein Barr virus infection.
    Chijioke O; Azzi T; Nadal D; Münz C
    J Leukoc Biol; 2013 Dec; 94(6):1185-90. PubMed ID: 23812328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for early-differentiated natural killer cells in infectious mononucleosis.
    Azzi T; Lünemann A; Murer A; Ueda S; Béziat V; Malmberg KJ; Staubli G; Gysin C; Berger C; Münz C; Chijioke O; Nadal D
    Blood; 2014 Oct; 124(16):2533-43. PubMed ID: 25205117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of human natural killer cells during Epstein-Barr virus infection.
    Münz C
    Crit Rev Immunol; 2014; 34(6):501-7. PubMed ID: 25597312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune response to primary EBV infection: a role for natural killer cells.
    Williams H; McAulay K; Macsween KF; Gallacher NJ; Higgins CD; Harrison N; Swerdlow AJ; Crawford DH
    Br J Haematol; 2005 Apr; 129(2):266-74. PubMed ID: 15813855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
    Ando S; Kawada JI; Watanabe T; Suzuki M; Sato Y; Torii Y; Asai M; Goshima F; Murata T; Shimizu N; Ito Y; Kimura H
    Oncotarget; 2016 Nov; 7(47):76793-76805. PubMed ID: 27732937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
    Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
    Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis.
    Mueller NE; Lennette ET; Dupnik K; Birmann BM
    Int J Cancer; 2012 Jun; 130(12):2886-91. PubMed ID: 21805472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
    Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
    Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.
    Tsuge I; Morishima T; Morita M; Kimura H; Kuzushima K; Matsuoka H
    Clin Exp Immunol; 1999 Mar; 115(3):385-92. PubMed ID: 10193407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.